Correlation Between Liaoning Chengda and Huadong Medicine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Liaoning Chengda and Huadong Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liaoning Chengda and Huadong Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liaoning Chengda Biotechnology and Huadong Medicine Co, you can compare the effects of market volatilities on Liaoning Chengda and Huadong Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liaoning Chengda with a short position of Huadong Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liaoning Chengda and Huadong Medicine.

Diversification Opportunities for Liaoning Chengda and Huadong Medicine

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Liaoning and Huadong is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Liaoning Chengda Biotechnology and Huadong Medicine Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Huadong Medicine and Liaoning Chengda is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liaoning Chengda Biotechnology are associated (or correlated) with Huadong Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Huadong Medicine has no effect on the direction of Liaoning Chengda i.e., Liaoning Chengda and Huadong Medicine go up and down completely randomly.

Pair Corralation between Liaoning Chengda and Huadong Medicine

Assuming the 90 days trading horizon Liaoning Chengda Biotechnology is expected to under-perform the Huadong Medicine. But the stock apears to be less risky and, when comparing its historical volatility, Liaoning Chengda Biotechnology is 1.75 times less risky than Huadong Medicine. The stock trades about -0.68 of its potential returns per unit of risk. The Huadong Medicine Co is currently generating about -0.33 of returns per unit of risk over similar time horizon. If you would invest  3,707  in Huadong Medicine Co on October 12, 2024 and sell it today you would lose (444.00) from holding Huadong Medicine Co or give up 11.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Liaoning Chengda Biotechnology  vs.  Huadong Medicine Co

 Performance 
       Timeline  
Liaoning Chengda Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Liaoning Chengda Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Huadong Medicine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Huadong Medicine Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Huadong Medicine is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Liaoning Chengda and Huadong Medicine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Liaoning Chengda and Huadong Medicine

The main advantage of trading using opposite Liaoning Chengda and Huadong Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liaoning Chengda position performs unexpectedly, Huadong Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Huadong Medicine will offset losses from the drop in Huadong Medicine's long position.
The idea behind Liaoning Chengda Biotechnology and Huadong Medicine Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum